Gastrectomy for cancer beyond life expectancy. A comprehensive analysis of oncological gastric surgery in Germany between 2008 and 2018.
clinical outcome
comorbidity
elderly patients
esophageal cancer
gastrectomy
gastric cancer
mortality
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
08
2022
accepted:
31
10
2022
entrez:
19
12
2022
pubmed:
20
12
2022
medline:
20
12
2022
Statut:
epublish
Résumé
Major gastric surgery for distal esophageal and gastric cancer has a strong impact on the quality of life, morbidity, and mortality. Especially in elderly patients reaching their life expectancy, the responsible use and extent of gastrectomy are imperative to achieve a balance between harm and benefit. In the present study, the reimbursement database (German Diagnosis Related Groups (G-DRG) database) of the Statistical Office of the Federal Republic of Germany was queried to evaluate the morbidity and mortality of patients aged above or below 75 years following gastrectomy. All patients in Germany undergoing subtotal gastrectomy (ST), total gastrectomy (T), or gastrectomy combined with esophagectomy (TE) for gastric or distal esophageal cancer (International Statistical Classification of Diseases and Related Health Problems Version 10 (ICD-10) C15.2, C15.5, and C16.0-C16.9) between 2008 and 2018 were included. Intraoperative and postoperative complications as well as comorbidities, in-hospital mortality, and the extent of surgery were assessed by evaluating ICD-10 and operation and procedure key (Operationen- und Prozedurenschlüssel) codes. A total of 67,389 patients underwent oncologic gastric resection in Germany between 2008 and 2018. In total, 21,794 patients received ST, 41,825 received T, and 3,466 received TE, respectively. In 304 cases, the combinations of these, in fact, mutually exclusive procedures were encoded. The proportion of patients aged 75 years or older was 51.4% (n = 11,207) for ST, 32.6% (n = 13,617) for T, and 28.1% (n = 973) for TE. The in-hospital mortality of elderly patients was significantly increased in all three groups. (p < 0.0001) General complications such as respiratory failure (p = 0.0054), acute renal failure (p < 0.0001), acute myocardial failure (p < 0.0001), and the need for resuscitation (ST/T: p < 0.0001/TE: p = 0.0218) were significantly increased after any kind of gastrectomy. Roux-en Y was the most commonly applied reconstruction technique in both young and elderly patients. Regarding lymphadenectomy, systematic D2 dissection was performed less frequently in older patients than in the younger collective in the case of ST and T as well as D3 dissection. Peritonectomy and hyperthermic intraperitoneal chemotherapy were uncommon in elderly patients alongside ST and T compared to younger patients (p < 0.0001). The clinical outcome of major oncological gastric surgery is highly dependent on a patient's age. The elderly show a tremendously increased likelihood of in-hospital mortality and morbidity.
Identifiants
pubmed: 36531049
doi: 10.3389/fonc.2022.1032443
pmc: PMC9747770
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1032443Informations de copyright
Copyright © 2022 Berlet, Weber, Neumann, Friess and Reim.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Gastric Cancer. 2011 Jun;11(2):116-21
pubmed: 22076212
World J Surg Oncol. 2022 Jan 7;20(1):10
pubmed: 34996481
Surg Endosc. 2021 Mar;35(3):1202-1209
pubmed: 32152675
World J Surg. 2012 Sep;36(9):2139-45
pubmed: 22610266
Chirurg. 2021 Jun;92(6):506-514
pubmed: 33496813
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Onco Targets Ther. 2016 Nov 07;9:6795-6800
pubmed: 27853375
Surg Today. 2019 Mar;49(3):187-196
pubmed: 30317492
Surg Endosc. 2018 Oct;32(10):4277-4283
pubmed: 29602987
Am Surg. 2011 Apr;77(4):488-92
pubmed: 21679562
World J Clin Cases. 2022 Feb 16;10(5):1498-1507
pubmed: 35211587
Ann Acad Med Singap. 2012 Oct;41(10):451-6
pubmed: 23138142
Am J Hematol. 2014 Jan;89(1):88-96
pubmed: 24122955
Expert Rev Anticancer Ther. 2021 May;21(5):511-522
pubmed: 33355020
Gastric Cancer. 2019 Jan;22(1):172-189
pubmed: 29846827
Jpn J Clin Oncol. 1998 Feb;28(2):112-5
pubmed: 9544826
J Robot Surg. 2021 Oct;15(5):741-749
pubmed: 33151485
Aging Clin Exp Res. 2020 Sep;32(9):1647-1673
pubmed: 32651902
World J Surg Oncol. 2016 Mar 31;14:90
pubmed: 27030355
Scand J Surg. 2022 Apr-Jun;111(2):14574969221096193
pubmed: 35611500
Ann Surg Oncol. 2010 Jun;17(6):1589-96
pubmed: 20099039
Surg Today. 2016 Feb;46(2):224-8
pubmed: 25911190
BMC Surg. 2021 Nov 19;21(1):399
pubmed: 34798854